Signifier Medical Technologies raises £7.7m in a Series C round led by Alan Howard to advance sleep disorder treatments
Alan Howard led the Series C round, with participation from James Blair and The Pritzker Organization.
Signifier Medical Technologies is a medical technology company that develops patient-friendly therapies for sleep-disordered breathing. Founded in 2015, the firm provides non-invasive solutions to address the root causes of conditions such as obstructive sleep apnoea and primary snoring.
Signifier Medical Technologies has secured £7.7m in a Series C funding round led by Alan Howard. The financing also drew participation from James Blair and existing backer The Pritzker Organization.
The capital will support the company as it scales operations and infrastructure for the global commercial rollout of its non-invasive neurostimulation devices designed to treat snoring and mild sleep apnea.
Investor perspective
"I look for companies that are addressing extensive market opportunities, are rapidly growing, and have experienced leadership teams. I strongly believe Signifier is one of those companies, and I am pleased to support its transformational innovation to address sleep and breathing disorders and chronic care management."
Alan Howard
VC investor and co-founder of Brevan Howard, Alan Howard
Use of funds
- 01Scale operations
- 02Build out infrastructure
Investors
Categories
About the company
Signifier Medical Technologies
Signifier Medical Technologies develops non-invasive therapies for sleep-disordered breathing.